• Privacy policy
  • T&C’s
  • About Us
    • FAQ
  • Contact us
  • Guest Content
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
    • Lottery Results
      • Lotto
      • Set For Life
      • Thunderball
      • EuroMillions
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
The London Economic
No Result
View All Result
Home News

EU threatens AstraZeneca with export ban as France and Poland increase lockdown measures

“This is a message to AstraZeneca: You fulfil your part of the deal toward Europe before you start to deliver to other countries.”

Joe Mellor by Joe Mellor
2021-03-20 13:54
in News
Credit;PA

Credit;PA

FacebookTwitterLinkedinEmailWhatsapp

The European Union’s executive arm has said AstraZeneca could face export bans to countries outside the bloc if it does not speed up its delivery of the promised amount of vaccines. It comes as France and Poland have stepped up their lockdown measures.

The move comes as the European Commission increases the pressure on pharmaceutical companies to speed up their vaccine delivery to the continent as virus cases increase in many member countries.

European Commission president Ursula von der Leyen said: “We have the possibility to ban planned exports.

Coronavirus graphic
(PA Graphics)

“This is a message to AstraZeneca: You fulfil your part of the deal toward Europe before you start to deliver to other countries.”

Speaking to German media group Funke, Ms von der Leyen said the contract between the EU and AstraZeneca clearly regulates how much vaccines the EU receives from AstraZeneca’s plants inside the EU and in the UK.

However, Ms von der Leyen added, “we didn’t get anything from the Brits while we are delivering vaccines to them”.

She said the commission had sent a “formal reminder” to AstraZeneca regarding this issue.

Europe is a powerhouse in science.

But while we're good at making science with money, we need to get better at making money out of science.

Today, we launch the European Innovation Council to support researchers and turn their ideas into products on the market. #EUeic

— Ursula von der Leyen (@vonderleyen) March 18, 2021

AstraZeneca’s coronavirus vaccine is one of three approved for use in the EU.

However, its usage has been overshadowed by several problems, including a slow start, recurring delivery problems and a temporary ban for several days earlier this week in many EU member countries after reports of blood clots in some recipients of the vaccine.

RelatedPosts

Council leader says St George’s flag is ‘intimidating’ and has been ‘co-opted by far-right’

Vladimir Putin lists his three demands to end Russia’s invasion of Ukraine

Government takes steps to appeal court ruling banning asylum seekers from Epping hotel

Israeli minister says ‘gates of hell will open’ on Gaza City

Most countries in the EU have resumed giving AstraZeneca jabs again on Friday as infection numbers spike across the continent.

The Oxford/AstraZeneca vaccine, which is cheaper and easier to store than others, is seen as critical to ending the coronavirus pandemic.

France and Poland

France and Poland have reintroduced partial lockdowns as both countries battle a sharp rise in Covid infections in recent weeks. Germany has also seen a spike in cases.

Some 21 million people in 16 areas of France, including the capital Paris, are affected as the country fears a third wave.

In Poland, non-essential shops, hotels, cultural and sporting facilities are now closed for three weeks.

The country has the highest new daily rates of Covid cases since November.

Parisians packed inter-city trains leaving the French capital and crammed into shops Friday ahead of a new lockdown aimed at stemming a surge in coronavirus infections.

Related: Harry pens foreword of book for children of health workers lost to Covid and reflects on Diana’s death

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

No Result
View All Result
  • Home
  • News
  • Politics
  • Lottery Results
    • Lotto
    • Set For Life
    • Thunderball
    • EuroMillions
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Privacy policy
  • Contact us

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

← Bemused reactions after Naga Munchetty apologised for liking tweets ← Will the BBC sign him up? Lee Hurst slammed for ‘creepy’ Greta Thunberg tweet
No Result
View All Result
  • Home
  • News
  • Politics
  • Lottery Results
    • Lotto
    • Set For Life
    • Thunderball
    • EuroMillions
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Privacy policy
  • Contact us

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

-->